Pre-publicity prophylaxis or “PrEP” is the use of an antiretroviral medication by HIV-unfavorable individuals to lower the risk of HIV acquisition. These vessels enable the blood to circulate from the peripheral capillary beds or to bypass them by currently being shunted directly